Navigation Links
Xlumena, Inc. Closes $7M Series B Venture Financing Round
Date:4/28/2011

MOUNTAIN VIEW, Calif., April 28, 2011 /PRNewswire/ -- Xlumena, a privately held provider of innovative technology for the interventional endoscopist and endoscopic surgeon, today announced it has successfully closed its Series B financing.

The current round of financing was led by new investor, Aperture Venture Partners, LLC and joined by Western Technology Investment. In conjunction with the financing, Eric Sillman of Aperture Venture Partners and Avi Kometz, MD of Ascent Biomedical Ventures will join Xlumena's Board of Directors.  "Xlumena has tremendous potential to deliver innovative devices to the emerging field of interventional and therapeutic endoscopy.  We are excited to lead the Series B financing and to begin collaborating with Xlumena's team to expand the impact of their novel technologies," stated Eric Sillman, General Partner of Aperture Venture Partners.

Also participating in the current round of financing were existing institutional investors Prism Ventures, Charter Life Sciences and Ascent Biomedical Ventures. "We are pleased to close our Series B with Aperture as the lead. This financing will support our market introductions in the US and Europe.  We are very fortunate to have top-tier investors supporting Xlumena's growth," stated Michael Allen, President and CEO of Xlumena.

About Xlumena, Inc.

Xlumena, Inc. is a privately-held interventional endoscopy-focused medical device company based in Mountain View, California.  The Company has a number of advanced therapeutic devices in various stages of development, including the NAVIX™ Access Device (FDA-cleared) and the AXIOS™ Stent and Delivery System (CE marked).  Formed in 2008 by Kenneth Binmoeller, MD (California Pacific Medical Center) and Michael Allen, Xlumena has raised $19M from venture capital sources to date.

For more information: http://xlumena.com  


'/>"/>
SOURCE Xlumena, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CoDa Therapeutics Closes $19 Million Series B Financing Round
2. Benvenue Medical Closes $35.5 Million Series C Financing
3. PixelOptics Closes $45 Million Financing
4. AnaBios Corporation Closes Series A Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Closes $1.1M Financing
7. Patient Safety Technologies, Inc. Closes $7.1 Million Common Stock Offering
8. BridgePoint Medical Closes $9.1 Million Series C Financing
9. Palatin Technologies, Inc. Closes $23 Million Public Offering
10. Sonoma Orthopedic Products® Closes $22 Million Series D Financing
11. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
Breaking Medicine Technology:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Lake Park ... smiles by using Invisalign® in Lutz, FL. With the help of this ... and aesthetics with fewer potential complications, more discretion and less pain. , Drs. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care ... on preventative care with all my patients to alleviate possible future issues. I am pleased ... contact my office and my trained staff will assist you in any way possible.” , ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
Breaking Medicine News(10 mins):